Literature DB >> 19302906

Impact of illegal trade on the quality of epoetin alfa in Thailand.

Fotis Fotiou1, Suresh Aravind, Ping-Ping Wang, Osot Nerapusee.   

Abstract

BACKGROUND: Reports from the World Health Organization have suggested that counterfeit medicines pose a serious problem in developing countries. An investigation of anti-erythropoietin antibody-mediated pure red cell aplasia in Thailand found evidence of drug smuggling, which may have serious safety implications.
OBJECTIVE: This study assessed the authenticity and quality of epoetin alfa samples in Thailand.
METHODS: Samples of epoetin alfa-prefilled syringes were collected from the pharmacies at 2 major hospitals (62 samples), 8 retail pharmacies (41 samples), and Thai authorities (30 samples confiscated from smugglers at 2 airports, and 6 samples from a condominium used by smugglers). These samples were tested against the European Union Pharmacopeia specifications for aggregate content in epoetins of <2%. The integrity of epoetin alfa distribution channels, coldchain processes (maintenance at 2 degrees C-8 degrees C), primary and secondary packaging components (eg, batch number, expiration date, appearance, letter size), and company's confidential features (eg, nature of the ink, type and quality of the paper, other covered features) were also investigated. The main outcome measures were protein aggregate content, determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blotting; and isoform distribution, assessed by isoelectric focusing and Western blotting.
RESULTS: Epoetin alfa samples obtained from the company's cold-chain and authorized distribution channels met all quality standards, as did all epoetin alfa samples obtained from the hospital pharmacies. However, evidence showed that some samples were being smuggled or sold illegally through certain unauthorized retail pharmacies. The epoetin alfa samples obtained from both airports and the condominium were stored improperly at room temperature. Aggregate levels exceeded the specification of <2% in 11 samples from 2 of the retail pharmacies (range, 1.2%-3.1%), 15 samples from the Dongmuang Airport (range, 2.2%-17.0%), and all 6 samples from the condominium (range, 10.5%-19.8%). All samples from the 2 hospitals, 8 retail pharmacies, and Suvarnabhumi Airport had the authentic 6 isoform bands. Samples from Dongmuang Airport and the condominium appeared to have the 6 characteristic bands, but positive confirmation was difficult because of band smearing caused by a high level of aggregates. All features of primary and secondary packaging were found to be authentic.
CONCLUSIONS: This investigation found evidence that some epoetin alfa samples were smuggled into Thailand without proper cold chain, contained high levels of protein aggregates, and were sold illegally through certain retail pharmacies. The Thai authorities have intervened to stop such unauthorized products from reaching patients. Strenuous efforts must be made to prevent illegal cross-border smuggling of biopharmaceuticals without proper cold chain because of the serious safety implications for patients in developing countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302906     DOI: 10.1016/j.clinthera.2009.02.014

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  11 in total

1.  Biosimilars-why terminology matters.

Authors:  Martina Weise; Marie-Christine Bielsky; Karen De Smet; Falk Ehmann; Niklas Ekman; Gopalan Narayanan; Hans-Karl Heim; Esa Heinonen; Kowid Ho; Robin Thorpe; Camille Vleminckx; Meenu Wadhwa; Christian K Schneider
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

2.  Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.

Authors:  Andreas Seidl; Otmar Hainzl; Marleen Richter; Robert Fischer; Stephan Böhm; Britta Deutel; Martin Hartinger; Jörg Windisch; Nicole Casadevall; Gerard Michel London; Iain Macdougall
Journal:  Pharm Res       Date:  2011-11-18       Impact factor: 4.200

Review 3.  Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review.

Authors:  Marianne Heibert Arnlind; Linda Fryklund; Sigurd Vitols; Göran Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2016-07-21       Impact factor: 2.953

4.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

5.  Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).

Authors:  Iain C Macdougall; Nicole Casadevall; Francesco Locatelli; Christian Combe; Gerard M London; Salvatore Di Paolo; Andreas Kribben; Danilo Fliser; Hans Messner; John McNeil; Paul Stevens; Antonio Santoro; Angel L M De Francisco; Paul Percheson; Anna Potamianou; Arnaud Foucher; Daniel Fife; Véronique Mérit; Els Vercammen
Journal:  Nephrol Dial Transplant       Date:  2014-09-19       Impact factor: 5.992

Review 6.  Posttranslational Modifications and the Immunogenicity of Biotherapeutics.

Authors:  Roy Jefferis
Journal:  J Immunol Res       Date:  2016-04-14       Impact factor: 4.818

7.  Body Builder's Nightmare: Black Market Steroid Injection Gone Wrong: a Case Report.

Authors:  Or Friedman; Ehud Arad; Oded Ben Amotz
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-29

8.  An authenticity survey of herbal medicines from markets in China using DNA barcoding.

Authors:  Jianping Han; Xiaohui Pang; Baosheng Liao; Hui Yao; Jingyuan Song; Shilin Chen
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

9.  Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington
Journal:  JAMA Netw Open       Date:  2018-08-03

10.  Substandard and Falsified Medicines in Myanmar.

Authors:  Mirai Sakuda; Naoko Yoshida; Takashi Takaoka; Tomoko Sanada; Mohammad Sofiqur Rahman; Tsuyoshi Tanimoto; Theingi Zin; Kazuko Kimura; Hirohito Tsuboi
Journal:  Pharmacy (Basel)       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.